CIS is First in the Country to Use New Closure Device


Pictured from left to right are: Theresa Kaiser, RT; Jason Vidrine, RN; Dr. Robert Menuet; Chad Thompson, RN; Elizabeth Borne, RT; Nick Trahan, RN; Chelsie Ledoux, RT and Bart Fontenot, Cordis Rep.

OPELOUSAS- On Thursday, February 24, Dr. Robert Menuet, interventional cardiologist at Cardiovascular Institute of the South (CIS), and the Opelousas General Health System cath lab team were the first in the country to use the latest version of the Mynx closure device. 

The MYNX® product family utilizes the proprietary GRIP™ sealant to seal the artery opening. The GRIP™ sealant, comprised of polyethylene glycol, grips the artery, providing a secure close.  The sealant dissolves within 30 days, leaving nothing permanently behind but a healed artery. 

“This updated technology offers the security of mechanical closure with the safety of a sealant in the extravascular tissue tract,” explained Dr. Menuet.  “This closure option is patient-friendly, with no need for sutures, clamping or metal implants.”

The MYNXGRIP® Vascular Closure Device is manufactured by Cardinal Health and is part of the Cordis portfolio.


Latest News

CIS Staff

Written by CIS Staff